Wikidata

(Q63814377)

English

A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)

clinical trial

In more languages

Statements

title
A Phase III, Multicenter, Open-Label Randomized Trial Comparing the Efficacy of GA101 (RO5072759) in Combination With CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL) (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Colombia
0 references
Denmark
0 references
Germany
0 references
Hungary
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Panama
0 references
Peru
0 references
Poland
0 references
Serbia
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Switzerland
0 references
Taiwan
0 references
Thailand
0 references
United Kingdom
0 references
start time
26 July 2011
0 references
end time
29 April 2016
0 references
number of participants
1,418
0 references
research intervention
Caelyx
0 references
prednisone
0 references
prednisolone
0 references
(RS)-cyclophosphamide
0 references
rituximab
0 references
doxorubicin
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63814377&oldid=1857396036"